These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10717758)

  • 21. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
    Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
    PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental studies on combinations of pyronaridine/primaquine versus chloroquine/primaquine.
    Shao BR; Zhan CQ; Chen KY; Ye XY; Lin BY; Ha SH; Zhang JX
    Chin Med J (Engl); 1990 Dec; 103(12):1024-6. PubMed ID: 2127247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyronaridine: yet another promising antimalarial substance from China.
    Ceylon Med J; 1996 Sep; 41(3):123-4. PubMed ID: 8917979
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pyronaridine--a new antimalarial drug].
    Shao BR
    Zhonghua Nei Ke Za Zhi; 1985 Nov; 24(11):691-2. PubMed ID: 3914406
    [No Abstract]   [Full Text] [Related]  

  • 25. [Stability of drug resistance of a pyronaridine-resistant line of Plasmodium berghei].
    Shao BR; Ye XY; Zheng H
    Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):183-05. PubMed ID: 2943123
    [No Abstract]   [Full Text] [Related]  

  • 26. Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon.
    Ramharter M; Kurth F; Schreier AC; Nemeth J; Glasenapp Iv; Bélard S; Schlie M; Kammer J; Koumba PK; Cisse B; Mordmüller B; Lell B; Issifou S; Oeuvray C; Fleckenstein L; Kremsner PG
    J Infect Dis; 2008 Sep; 198(6):911-9. PubMed ID: 18694333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Polychemoresistant Plasmodium falciparum malaria, successfully treated with a benzonaphthyridine].
    Lapierre J
    Nouv Presse Med; 1982 Feb; 11(9):673. PubMed ID: 7041087
    [No Abstract]   [Full Text] [Related]  

  • 28. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
    Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
    Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyronaridine against multiresistant falciparum malaria.
    Peters W
    Lancet; 1996 Mar; 347(9001):625. PubMed ID: 8596361
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of the development of the hepatic stages of Plasmodium yoelii nigeriensis by antihistaminic agents.
    Singh N; Puri SK
    Ann Trop Med Parasitol; 1999 Jun; 93(4):419-22. PubMed ID: 10656045
    [No Abstract]   [Full Text] [Related]  

  • 31. Adaptive immunity is essential in preventing recrudescence of Plasmodium yoelii malaria parasites after artesunate treatment.
    Claser C; Chang ZW; Russell B; Rénia L
    Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28664674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Longitudinal surveillance of sensitivity of Plasmodium falciparum to pyronaridine in south Yunnan].
    Yang H; Liu D; Huang K; Zhang C; Li C
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(2):81-3. PubMed ID: 12078227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined use of pyronaridine, sulfadoxine and primaquine in areas with chloroquine-resistant falciparum malaria].
    Che LG; Huang KG; Yang HL; Yu L; Lin ZL; Huang R
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1987; 5(3):194-6. PubMed ID: 3329070
    [No Abstract]   [Full Text] [Related]  

  • 34. Within-host selection of drug resistance in a mouse model of repeated interrupted treatment of Plasmodium yoelii infection.
    Nuralitha S; Siregar JE; Syafruddin D; Hoepelman AIM; Marzuki S
    Malar J; 2017 May; 16(1):216. PubMed ID: 28535797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimalarial and toxic effect of triple combination of pyronaridine, sulfadoxine and pyrimethamine.
    Shao BR; Huang ZS; Shi XH; Zhan CQ; Meng F; Ye XY; Huang J; Ha SH
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):257-63. PubMed ID: 2692191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyronaridine-artesunate for uncomplicated falciparum malaria.
    Nosten FH
    Lancet; 2010 Apr; 375(9724):1413-4. PubMed ID: 20417841
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic effect of pyronaridine in plain tablets and enteric-coated tablets in falciparum malaria patients].
    Huang ZS; Feng Z; Meng F; Zeng LH; Lin X; Zheng Y; Xing QF; Guo RN
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1989; 7(1):19-21. PubMed ID: 2670309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.
    Kondaparla S; Soni A; Manhas A; Srivastava K; Puri SK; Katti SB
    Bioorg Chem; 2017 Feb; 70():74-85. PubMed ID: 27908538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyronaridine.
    Foster S
    Lancet; 1996 Apr; 347(9009):1190. PubMed ID: 8609792
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children.
    Ringwald P; Bickii J; Basco LK
    Clin Infect Dis; 1998 Apr; 26(4):946-53. PubMed ID: 9564481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.